Jin Wei Kou
Director of Finance/CFO chez Universal Bespoke Condiment Co., Ltd.
Profil
Jin Wei Kou is currently the Chief Financial Officer & Vice General Manager at Universal Bespoke Condiment Co., Ltd.
Prior to this, she worked as the Managing Director at Marcum Asia CPAs LLP from 2008 to 2016 and as a Senior Associate at Deloitte Touche Tohmatsu CPA Ltd.
from 2005 to 2008.
She also briefly served as the Chief Financial Officer & Vice General Manager at Salion Food Condiment Co., Ltd.
from 2017 to 2018.
Additionally, she is the Chief Financial & Accounting Officer at Xynomic Pharmaceuticals Holdings, Inc. Ms. Kou received her undergraduate and graduate degrees from Peking University in 2003 and 2005, respectively.
Postes actifs de Jin Wei Kou
| Sociétés | Poste | Début |
|---|---|---|
Universal Bespoke Condiment Co., Ltd.
 Universal Bespoke Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Universal Bespoke Condiment Co., Ltd. is an investment holding company. It is involved in research and development, manufacturing and sale of compound condiment and extracts products. The company was founded on August 23, 2016 and is headquartered in Hong Kong. | Director of Finance/CFO | 21/07/2017 |
Anciens postes connus de Jin Wei Kou
| Sociétés | Poste | Fin |
|---|---|---|
Salion Food Condiment Co., Ltd.
 Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Director of Finance/CFO | 01/01/2018 |
Marcum Asia CPAs LLP
 Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The private company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Chief Executive Officer | 01/01/2016 |
Deloitte Touche Tohmatsu CPA Ltd.
 Deloitte Touche Tohmatsu CPA Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu CPA Ltd. is a Chinese company that provides accounting, tax, audit, and assurance services. The company is based in Shanghai, China. The company was founded in 1993. | Corporate Officer/Principal | 01/04/2008 |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Director of Finance/CFO | - |
Formation de Jin Wei Kou
| Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Deloitte Touche Tohmatsu CPA Ltd.
Deloitte Touche Tohmatsu CPA Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu CPA Ltd. is a Chinese company that provides accounting, tax, audit, and assurance services. The company is based in Shanghai, China. The company was founded in 1993. | Commercial Services |
Marcum Asia CPAs LLP
Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The private company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
Universal Bespoke Condiment Co., Ltd.
Universal Bespoke Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Universal Bespoke Condiment Co., Ltd. is an investment holding company. It is involved in research and development, manufacturing and sale of compound condiment and extracts products. The company was founded on August 23, 2016 and is headquartered in Hong Kong. | Consumer Non-Durables |
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Consumer Non-Durables |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
